Dongmei Sun

Dongmei Sun

Auto-generated profile, based on publicly available information

Dongmei Sun

Research and Development Department of Technology, Guangdong Yifang Pharmaceutical Co., Ltd., Foshan, 528200, Guangdong, PR China

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

19 January 2017 in Biopharmaceutics & Drug Disposition
Verified
Journal Article
Closed access
PDF file
XZXiaohui Zeng
Xiaohui Zeng
DCDake Cai
Dake Cai
QZQiaohuang Zeng
Qiaohuang Zeng
ZCZhao Chen
Zhao Chen
GZGuoping Zhong
Guoping Zhong
YCYuxing Chen
Yuxing Chen

14 October 2013 in Journal of Microencapsulation
Verified
Journal Article
Closed access
PDF file
YTY. S. Tu
Y. S. Tu
DSD. M. Sun
D. M. Sun
JZJ. J. Zhang
J. J. Zhang
ZJZ. Q. Jiang
Z. Q. Jiang
YCY. X. Chen
Y. X. Chen
NYN. Yao
N. Yao
Objective: In this study, a novel andrographolide (AG) preparation formulation, niosomes, was prepared to improve the bioavailability and tissue distribution of AG. Methods: The niosomal formulation of AG was prepared by film hydration/sonication method and tissue distribution was measured by liquid chromatography-mass spectrometry (LC-MS) method in mice, and anti-hepatocellular carcinoma (anti-HCC) activity was examined by MTT method in HepG2. Results: Entrapment efficiency, drug-loading ratio and average particle size of AG niosomes were 72.36%, 5.90% and 206 nm, respectively. The tissue distribution in mice demonstrated that the AG niosomes were absorbed in liver much more than the free AG. Furthermore, the anti-HCC activity in HepG2 cells showed that there was no significant difference between free AG and AG niosomes. Conclusion: The present results suggest that AG niosomes may have a significant potential of liver targeting, which is valuable in chemotherapy of HCC.

16 May 2014 in Experimental and Therapeutic Medicine
Verified
Journal Article
Open access
PDF file
YTYaosheng Tu
Yaosheng Tu
DSDongmei Sun
Dongmei Sun
XZXiaohui Zeng
Xiaohui Zeng
NYNan Yao
Nan Yao
XHXuejun Huang
Xuejun Huang
YCYuxing Chen
Yuxing Chen
It has previously been demonstrated that curcumin possesses a hypocholesterolemic effect and potentiates numerous pharmacological effects of curcumin, however, the mechanisms underlying this hypocholesterolemic effect and the interaction between curcumin and piperine remain to be elucidated. In the present study, male Sprague‑Dawley rats were fed on a high‑fat diet (HFD) to establish a hyperlipidemia (HLP) model. Co‑administration of curcumin plus piperine was found to decrease the levels of total cholesterol (TC), triglyceride (TG) and low‑density lipoprotein cholesterol in the serum and liver, as well as increase the levels of fecal TC, TG and total bile acid, compared with administration of curcumin alone. Curcumin plus piperine also markedly increased the levels of high‑density lipoprotein cholesterol. Furthermore, compared with administration of curcumin alone, administration of curcumin plus piperine resulted in a significant upregulation of the activity and gene expression of apolipoprotein AI (ApoAI), lecithin cholesterol acyltransferase (LCAT), cholesterol 7α‑hydroxylase (CYP7A1) and low‑density lipoprotein receptor (LDLR). In conclusion, these results indicated that co‑administration of curcumin plus piperine potentiates the hypocholesterolemic effects of curcumin by increasing the activity and gene expression of ApoAI, CYP7A1, LCAT and LDLR, providing a promising combination for the treatment of HLP.

10 May 2016 in Tropical Journal of Pharmaceutical Research
Verified
Journal Article
Open access
PDF file
XZXiaohui Zxh Zeng
Xiaohui Zxh Zeng
DSDongmei Sdm Sun
Dongmei Sdm Sun
NYNan Yn Yao
Nan Yn Yao
YCYuxing Cyx Chen
Yuxing Cyx Chen
DCDake Cdk Cai
Dake Cdk Cai
LHLin Hl Huang
Lin Hl Huang
Purpose: To investigate the pathogenesis of high fat diet (HFD)-induced hyperlipidemia (HLP) in mice, rats and hamsters and to comparatively evaluate their sensitivity to HFD. Methods: Mice, rats and hamsters were fed with high-fat diet formulation (HFD, n = 8) or a control diet (control, n = 8) for 4 weeks. Changes in body weight, relative liver weight, serum lipid profile, expressions of hepatic marker gene of lipid metabolism and liver morphology were observed in three hyperlipidemic models. Results: Elevated total cholesterol (TC), triglyceride, low density lipoprotein-cholesterol (LDL-C) and high density lipoprotein-cholesterol (HDL-C) levels and body weight were observed in all hyperlipidemic animals (p < 0.05), while hepatic steatosis was manifested in rat and hamster HLP models, and increased hepatic TC level was only seen (p < 0.05) in hamster HLP model. Suppression of HMG-CoA reductase and up-regulation of lipoproteinlipase were observed in all HFD groups. Hepatic gene expression of LDLR, CYP7A1, LCAT, SR-B1, and ApoA I, which are a response to reverse cholesterol transport (RCT), were inhibited by HFD in the three models. Among these models, simultaneous suppression of HMG-CR, LCAT, LDLR and SR-BI and elevated LPL were features of the hamster model. Conclusion: As the results show, impaired RCT and excessive fat accumulation are major contributors to pathogenesis of HFD-induced murine HLP. Thus, the hamster model is more appropriate for hyperlipidemia research. Keywords: Hyperlipidemic model, Murine, Hamster, mRNA, Reverse cholesterol transport, High-fat diet, Pathogenesis

14 February 2025 in Phytomedicine
Verified
Journal Article
Closed access
JKJun-Li Kang
Jun-Li Kang
JWJia-Wei Wang
Jia-Wei Wang
XCXiang-Dong Chen
Xiang-Dong Chen
QLQing Liu
Qing Liu
DZDe-Quan Zhu
De-Quan Zhu
HZHua Zhou
Hua Zhou